Ignite Creation Date:
2024-05-06 @ 8:45 AM
Last Modification Date:
2024-10-26 @ 12:04 PM
Study NCT ID:
NCT02812654
Status:
UNKNOWN
Last Update Posted:
2016-06-24
First Post:
2016-03-24
Brief Title:
Ifosfamide Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment
Sponsor:
AC Camargo Cancer Center
Organization:
AC Camargo Cancer Center
Organization Data
Organization:
AC Camargo Cancer Center
Class:
OTHER
Study ID:
194714
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AC Camargo Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None